Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
Nadine Abdallah, David Murray, Angela Dispenzieri, Prashant Kapoor, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Wilson Gonsalves, Eli Muchtar, Nelson Leung, David Dingli, Taxiarchis Kourelis, Rahma Warsame, Moritz Binder, Robert A. Kyle
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Lymphocytic Leukemia Research · Immunodeficiency and Autoimmune Disorders · Myeloproliferative Neoplasms: Diagnosis and Treatment
Correction to: Leukemia 10.1038/s41375-021-01501-0, published online 29 January 2022
The Funding information section was missing from this article and should have read ‘This work was supported by the Paul Calabresi K12 Career Development Award (CA90628-21).’.
The original article has been corrected.